Qualcomm Life Launches Its Wireless Health Solution in Europe - First Customers Include Telbios and Cystelcom

    Qualcomm Life Launches Its Wireless Health Solution in Europe - First
                   Customers Include Telbios and Cystelcom

- CE Certified 2net Platform and Hub and Integrated Customer Devices Showcased
at Telecare & Telehealth (TSA) 2012 in Birmingham, England; Company Will Also
Exhibit at Medica 2012 in Dusseldorf, Germany -

PR Newswire

BIRMINGHAM, England, Nov. 12, 2012

BIRMINGHAM, England, Nov. 12, 2012 /PRNewswire/ --Qualcomm Life, Inc., a
subsidiary of Qualcomm Technologies, Inc. (QTI), today announced the
availability of its wireless healthcare services offering in Europe. Qualcomm
Life's 2net^™ Platform and Hub are designed to enable medical device
manufacturers and service providers to wirelessly connect their medical
devices via a secure, cloud-based solution so that biometric information is
easily accessible by device users, their healthcare providers and caregivers.
The 2net Platform and Hub are each individually certified as Class I Medical
Devices in Europe, and FDA listed as a Medical Device Data System (MDDS) in
the U.S. The announcement took place at the International Telecare &
Telehealth Conference (TSA) being held at the Hilton Birmingham Metropole
Hotel from November 12-14.

"We have a number of customers in Europe and the U.S. who want to extend their
mobile health solutions in multiple regions around the world, and they need to
provide a reliable service that is not impacted by geographic boundaries,"
said Rick Valencia, vice president and general manager of Qualcomm Life.
"Launching our wirelessly enabled healthcare ecosystem into Europe is another
step toward the realization of our vision -- a world with access to healthcare
anytime and anywhere."

To view the multimedia assets associated with this release, please click:

Two of Qualcomm Life's first European customers are Telbios and Cystelcom.
Telbios is a leading service provider of remote health monitoring solutions
for chronic care and disease management in Italy. Telbios is working with
Qualcomm Life as its technology solution provider to reduce costs and remove
technological complexities. Qualcomm Life's wireless solution allows Telbios
to lower the economic and operational barriers required to expand and scale
its innovative chronic care services faster. By connecting to the 2net
Platform, Telbios will be able to combine data from several devices into one
data stream to allow for improved access and sharing of patient data,
improving care coordination for general practitioners.

Cystelcom, an engineering software development company that provides products
and services to the telecommunications industry, has formed the newly created
mHealthAlert. mHealthAlert offers an open remote monitoring platform for
chronic disease patients to reduce readmissions and the length of hospital
stay. Qualcomm Life's 2net Platform and Hub will provide added ease of use for
patient populations such as the elderly and chronically ill patients using the
mHealthAlert solution. Cystelcom will be distributing Qualcomm Life's 2net Hub
in the territory of Spain, selling to the Health Department of the autonomous
governments, insurance companies and private hospitals.

Mobile health holds significant potential in Europe to defray healthcare costs
and increase the quality and quantity of care, helping to address anticipated
shortages of qualified healthcare professionals. Globally, Europe has the
highest burden of chronic disease, and the continued increase in prevalence is
considered an epidemic by the World Health Organization (WHO), which estimates
chronic diseases will claim the lives of 52 million people in the European
region by 2030.

"There is a clear imperative for health services providers and manufacturers
to invest in remote monitoring solutions to improve patient outcomes and align
with preventive care initiatives. Europe's governing bodies have demonstrated
a commitment to robust pilots, such as the 3 Million Lives project sponsored
by the Department of Health in the U.K.," said Laurent Vandebrouck, managing
director of Qualcomm Life Europe. "Qualcomm Life has been helping its
customers pave the way for wireless health in the U.S., and this is an
exciting time to extend our services and offering in Europe."

The 2net Platform is designed as a secure end-to-end, technology-agnostic,
cloud-based service offering that interconnects health devices so that
information is easily accessible by device users and their healthcare
providers and caregivers. The 2net Hub is one of four gateways onto the
platform, and is a plug-and-play Class I Medical Device under the EU directive
93/42/EEC (MDD) that collects data from a patient's medical device and sends
the information to be stored in the 2net Platform over a mobile connection,
following encryption. A connection to the 2net Platform can also be obtained
through three additional gateways including mobile phones, other
mobile-enabled devices, and application program interfaces that connect to the
customer service platform. Connectivity is provided through a pan-European SIM
with no roaming fees allowing deployment of customer solutions anytime, in any
place and in any European country. More than 100 medical device manufacturers,
application developers, healthcare services companies and payors are in
various stages of integration with the 2net Ecosystem.

Qualcomm Life is showcasing the 2net Platform, Hub and its integrated
customers' devices at Booth #24 and also is participating in the Self Care
Zone at TSA 2012. Don Jones,  vice president, global strategy and market
development for Qualcomm Life, will participate in the panel discussion on
"The Big Debate: Getting behind the headlines, can telehealth and telecare
really facilitate a transformation in services?" on November 13, from 2:10 – 3
p.m. GMT.

Qualcomm Life also will exhibit in the Wireless Health Pavilion at Booth #E04
in Hall #15 at Medica 2012, taking place November 14-17 in Dusseldorf,

About Qualcomm Technologies, Inc.

Qualcomm Technologies, Inc. (QTI), a wholly owned subsidiary of Qualcomm
Incorporated (NASDAQ: QCOM), is redefining the way people incorporate wireless
devices and services into everyday life. QTI and its subsidiaries operate
substantially all of Qualcomm's research and development activities, and
product and services businesses, including Qualcomm's semiconductor business,
QCT. QTI's developments enable opportunities across the wireless and wired
value chains by making devices and networks faster, content richer and
communications more personal and affordable to people everywhere. For more
information, go to www.qualcomm.com.

Qualcomm is a registered trademark of Qualcomm Incorporated. 2net is a
trademark of Qualcomm Incorporated. All other trademarks are the property of
their respective owners.

Media Contacts:
Emily Kilpatrick, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com

Jamie Eisinger, Qualcomm Life, Inc.
Phone: 1-858-845-1033
Email: jeisinge@qti.qualcomm.com

Warren Kneeshaw, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com

SOURCE Qualcomm Technologies, Inc.
Press spacebar to pause and continue. Press esc to stop.